# A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain

> clinical trial · VERIFIED · 2026-07-31

Status: RECRUITING · Sponsor: Beijing Tiantan Hospital · Condition: Pain, Intractable

- Company: Beijing Tiantan Hospital
- Sector: Pain, Intractable
- Primary source: https://clinicaltrials.gov/study/NCT06596681

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.